Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer or metabolic disease
-
characters in Japanese. Include the research concept you wish to pursue.) If there is another main laboratory you wish to belong to, indicate that name and prepare a statement of reasons separately. Please
-
autoimmunity. The overarching goal of the Wu lab is to harness innate immunity to develop new immunotherapies for cancer and inflammatory diseases. Our recent research has been published in top-tier journals
-
to intervene the malignancies 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell sequencing chor high throughput proteomics 4) development of small molecule drugs and PROTAC
-
interest in methods development Experience in one or more of the following areas: algorithms development, transcriptome analysis, RNA modifications, statistics, machine learning, long read RNA-Sequencing
-
visit here . As a successful candidate you will: · Focus on metabolic regulations of cardiovascular disease under cancer treatment and metabolic syndrome · Utilize multiple cutting-edge
-
role in developing our knowledge of the effect of radiation (microbeam +/- FLASH) on fibroblast and myeloid populations in pancreatic and bladder cancer models. About you The successful candidate must
-
Southwestern (UTSW) Medical Center in Dallas, seeks applications for multiple postdoctoral fellow positions to investigate memory mechanisms in the mammalian brain using innovative molecular, cellular
-
imaging techniques and/or behavioral testing in rodents is advantageous. It is an advantage to have expertise in genetic cell tracing techniques. Experience in managing mouse colonies with multiple
-
conduct laboratory-based research focusing on multiple myeloma and its precursor conditions. Based on the mission of the lab, the successful candidate will be responsible for identifying novel biomarkers